mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers

• Dustin A. Deming,

  Affiliation Division of Hematology and Oncology, Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Alyssa A. Leystra,

  Affiliation Department of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Mohammed Farhoud,

  Affiliation Comprehensive Cancer Center Small Animal Imaging Facility, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Laura Nettekoven,

  Affiliation Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Linda Clipson,

  Affiliation Department of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Dawn Albrecht,

  Affiliation Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Mary Kay Washington,

  Affiliation Department of Pathology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Ruth Sullivan,

  Affiliation Research Animal Resources Center, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Jamey P. Weichert,

  Affiliation Department of Radiology, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Richard B. Halberg

  * E-mail: rbhalberg@medicine.wisc.edu

  Affiliation Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯